Dr. Rhonda Patrick

And polycythemia is, I would say, a risk factor, right?

So, you know, how substantial is this?

I mean, I think I've read studies where it's like almost 25% of men have thicker blood that are on testosterone replacement therapy.

Now, it doesn't necessarily mean it's like

to the point where it has to be treated, but it is thicker, right?

It is like the hematocrit is thicker.

So, you know, how should men weigh these risks for the cardiovascular disease risk, the polycythemia?

So for people like listening or watching, that isn't a concern because it increases, you know, stroke risk.

It increases the potential for, you know, cardiovascular events as well.

So like, what are your thoughts on sort of weighing those risks?

So you're touching on an important point here that supraphysiologic level, like the amount that you wouldn't necessarily have in like a normal physiologically level.

I mean, I read a study where it was like 25 percent of men have this and it seems like it might be due to this like dosing, this injection protocol.

What's wrong with the cream?

Like, is that something that doesn't get your levels high enough or is it just like annoying to have to do every day?

Yeah.

I mean, I get that.

But like, you know.

like stroke risk, cardiovascular disease.

Okay.

What about other like parts of the risk profile?